Prescription Drug Marketing Act Re-Opening Sought By Rep. Emerson
Executive Summary
FDA needs to reopen its final rule implementing the Prescription Drug Marketing Act because it places an undue burden on small drug distributors, Rep. Emerson (R-Mo.) told the agency in a March 3 letter.
You may also be interested in...
FDA Allocates $13.5 Mil. For Inspection Requirements In FY 2001 Budget
FDA wants to allocate $13.5 mil. in the FY 2001 budget request to come closer to its statutory obligations to conduct inspections. The requirements call for biennial inspections of most FDA-regulated facilities.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011